You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

aldesleukin

Showing 1 - 25 of 188
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Seoul (TASO-001((TGF-ß2 targeting anti-sense oligonucleotide), Aldesleukin)

Recruiting
  • Solid Tumor
  • TASO-001((TGF-β2 targeting anti-sense oligonucleotide)
  • Aldesleukin
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 31, 2023

Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

Recruiting
  • Metastatic Melanoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

HIV Trial run by the NIAID (Aldesleukin)

Completed
  • HIV Infections
  • Aldesleukin
  • Bethesda, Maryland
    Natl Inst of Allergy & Infect Dis / Cln Ctr
Oct 27, 2021

Alzheimer Trial in Houston (Aldesleukin)

Completed
  • Alzheimer Disease
  • Aldesleukin
  • Houston, Texas
    Alireza Faridar
Apr 19, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Cervical Cancer, Renal Cancer, Urothelial Cancer Trial run by the NCI (Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood

Completed
Has Results
  • Cervical Cancer
  • +4 more
  • Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2022

Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Young TIL
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)

Completed
Has Results
  • Metastatic Melanoma
  • Aldesleukin
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022

Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester

Not yet recruiting
  • Clinical Stage IV Gastric Cancer AJCC v8
  • +4 more
  • Aldesleukin
  • +10 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 5, 2023

Metastatic Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (Aldesleukin)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Metastatic Melanoma
  • Aldesleukin
  • Los Angeles, California
  • +3 more
Jun 4, 2021

Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

Active, not recruiting
  • Metastatic Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Advanced Solid Tumor, Metastatic Cancer Trial in Miranda, Clayton, Heidelberg (AU-007, Aldesleukin)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Cancer
  • Miranda, New South Wales, Australia
  • +2 more
Jun 10, 2022

HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston

Active, not recruiting
  • HLA-A*0201 Positive Cells Present
  • +3 more
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,

Recruiting
  • Endocrine/Neuroendocrine
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Type1 Diabetes Trial in United Kingdom (Aldesleukin, Placebo)

Active, not recruiting
  • Type1 Diabetes
  • Aldesleukin
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
  • +4 more
Dec 15, 2021

HIV Trial in Stanford (Zidovudine, Aldesleukin)

Completed
  • HIV Infections
  • Stanford, California
    Stanford Univ School of Medicine
Oct 27, 2021

Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

Active, not recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Aldesleukin
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

HIV Trial in Pittsburgh (Zidovudine, Aldesleukin)

Completed
  • HIV Infections
  • Pittsburgh, Pennsylvania
    Univ of Pittsburgh Med School
Oct 27, 2021

Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)

Completed
  • Covid19
  • Ixekizumab
  • +3 more
  • Ribeirão Preto, SP, Brazil
  • +1 more
Jul 26, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022